← 產業報告目錄
Cannabis Inhaler Market Size, Share & Trends Analysis Report By Type (Cannabigerol (CBG), Tetrahydrocannabivarinic (THCV), Cannabidiol (CBD), Tetrahydrocannabinol (THC)), By Application (Sleep Disorders, Stress & Anxiety, Chronic Pain Management, Asthma, Others), By End-User, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-14頁數 190報告編號 INSIGHTACE-8eebaf776e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Cannabis Inhaler Market is positioned for steady expansion, with a projected CAGR of 9.5% from 2025 to 2034.
Cannabis Inhaler covers key industry insights & findings from the report:
The advent of the cannabis inhaler market is the cause of regulatory changes, technological advancements, changing consumer preferences, and increasi. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cannabis Inhaler Market Snapshot
Chapter 4. Global Cannabis Inhaler Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Clinical Trial/Pipeline Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Cannabigerol (CBG)
5.2.2. Tetrahydrocannabivarinic (THCV)
5.2.3. Cannabidiol (CBD)
5.2.4. Tetrahydrocannabinol (THC)
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
6.2.1. Sleep Disorders
6.2.2. Stress & Anxiety
6.2.3. Chronic Pain Management
6.2.4. Asthma
6.2.5. Others
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-User & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-User:
7.2.1. Hospitals
7.2.2. Retail Pharmacies
7.2.3. Specialized Health Centers
Chapter 8. Cannabis Inhaler Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
8.1.2. North America Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.1.3. North America Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
8.1.4. North America Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Cannabis Inhaler Market revenue (US$ Million) By Type, 2021-2034
8.2.2. Europe Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.2.3. Europe Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
8.2.4. Europe Cannabis Inhaler Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Cannabis Inhaler Market revenue (US$ Million) By Type, 2021-2034
8.3.2. Asia Pacific Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.3.3. Asia Pacific Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
8.3.4. Asia Pacific Cannabis Inhaler Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Cannabis Inhaler Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
8.4.2. Latin America Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.4.3. Latin America Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
8.4.4. Latin America Cannabis Inhaler Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Cannabis Inhaler Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
8.5.3. Middle East & Africa Cannabis Inhaler Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
8.5.4. Middle East & Africa Cannabis Inhaler Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Luxe
9.2.2. Fairwinds cannabis
9.2.3. H and T presspart manufacturing LTD.
9.2.4. Koi CBD
9.2.5. MUV
9.2.6. Vectura Group plc
9.2.7. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們